Clinical Trial Update: Valacyclovir Suppression to Improve the Stability of Vaginal Flora Among HSV-2 Seropositive Women [NA]

View source ↗

Summary

A clinical trial evaluating valacyclovir suppression to stabilize vaginal flora in HSV-2 seropositive women has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Vaginosis
• Herpes Simplex Virus Type Infection

Drugs mentioned

• Valacyclovir (Valacyclovir)

Snippet

Sponsor: University of Pittsburgh | Conditions: Bacterial Vaginosis, Herpes Simplex Virus Type II | NA | Status: WITHDRAWN